About this trial
This randomized controlled trial aims to determine whether access to a mental health app improves resilience and reduces depressive symptoms among medical students over a three-month period.
Compared to the control group, researchers hypothesized that medical students in the intervention group are expected to show:
* Significant reductions in depressive symptoms and greater improvements in resilience after three months of usage. * Significant reduction in thoughts of self-harm and anxiety, and improvement in self-esteem after three months of usage.
Researchers will compare two groups to evaluate the app's impact on wellbeing:
* Intervention group: Receives immediate full access to the mental health app. * Control group: Receives basic, without full access to the mental health app.
Participants will explore and experience the various features offered in the mental health app over a three-month period.
Eligibility criteria
Qualifiers
Aged 18 to 30;
Enrolled in medical school (preclinical or clinical years);
Owns a smartphone;
Able to read and understand English.
Disqualifiers
Does not consent to study.
Trial design
Treatments tested in this trial
- Full digital mental health intervention
- Basic digital mental health intervention
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.